
SalivaTech is a biotechnology company spun out of Keio University's Institute for Advanced Biosciences. They have developed a saliva-based disease screening technology, utilizing metabolomics analysis and AI for early detection. Their mission is to contribute to early disease discovery and intervention through their screening test business, acting as a bridge between self-care and medical treatment, and continuously advancing technology through academia collaboration. Their flagship product, SalivaChecker®, is a cancer risk test that analyzes metabolites in saliva to identify current cancer risks. The company aims to make healthcare more accessible and proactive through simple, non-invasive testing.

SalivaTech is a biotechnology company spun out of Keio University's Institute for Advanced Biosciences. They have developed a saliva-based disease screening technology, utilizing metabolomics analysis and AI for early detection. Their mission is to contribute to early disease discovery and intervention through their screening test business, acting as a bridge between self-care and medical treatment, and continuously advancing technology through academia collaboration. Their flagship product, SalivaChecker®, is a cancer risk test that analyzes metabolites in saliva to identify current cancer risks. The company aims to make healthcare more accessible and proactive through simple, non-invasive testing.